<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr (EB) virus induces a new <z:chebi fb="0" ids="16898">pyrimidine</z:chebi> deoxynucleoside kinase [<z:chebi fb="0" ids="17748">thymidine</z:chebi> kinase (dTk)] activity in Raji B lymphocyte cells after <z:e sem="disease" ids="C0038826" disease_type="Disease or Syndrome" abbrv="">superinfection</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This dTk activity is also present in small amounts in the HR-1 virus-producer cell line and in larger amounts in the B95-8 virus-producer line </plain></SENT>
<SENT sid="2" pm="."><plain>The dTk activity induced by EB virus coelutes from <z:chebi fb="0" ids="52153">DEAE</z:chebi>-cellulose columns with deoxycytidine kinase (dCk) activity and elutes as a broad peak well separated from the large peaks of cellular dTk and dCk activities </plain></SENT>
<SENT sid="3" pm="."><plain>This EB virus-induced <z:chebi fb="0" ids="16898">pyrimidine</z:chebi> deoxynucleoside kinase activity from HR-1 cells differs from cellular kinases in most basic biochemical properties but shares certain properties with the <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> virus dTk </plain></SENT>
</text></document>